Add-on Acquisition • Medical Products

Watson Pharmaceuticals Acquires Uteron Pharma SA

On January 23, 2013, Watson Pharmaceuticals acquired medical products company Uteron Pharma SA for 150M USD

Acquisition Context

This is Watson Pharmaceuticals’ 4th transaction in the Medical Products sector.
This is Watson Pharmaceuticals’ 4th largest (disclosed) transaction.
This is Watson Pharmaceuticals’ 1st transaction in Belgium.

Explore All 2732 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	January 23, 2013
Target	Uteron Pharma SA
Sector	Medical Products
Buyer(s)	Watson Pharmaceuticals
Deal Type	Add-on Acquisition
Deal Value	150M USD

Target Company

Uteron Pharma SA

Grâce-Hollogne, Belgium

Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Watson Pharmaceuticals

Florham Park, New Jersey, United States

Category	Company
Founded	1931
Sector	Medical Products
Employees	1,325

DESCRIPTION

Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

Deal Context for Buyer	#
Overall	9 of 9
Sector: Medical Products	4 of 4
Type: Add-on Acquisition	5 of 5
Country: Belgium	1 of 1
Year: 2013	1 of 1
Size (of disclosed)	4 of 7

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2012-10-31	Pharmaco Hf. Hafnarfirdi,, Iceland Pharmaco Hf. engages in the development, manufacture, and sale of generic pharmaceuticals.	Buy	€4.3B

DATE

TARGET

DEAL TYPE

VALUE

2012-10-31

Pharmaco Hf.

Hafnarfirdi,, Iceland

Pharmaco Hf. engages in the development, manufacture, and sale of generic pharmaceuticals.

Buy

€4.3B

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Belgium M&A - 2013 M&A